The antiestrogen ICI 182780 disrupts estrogen receptor nucleocytoplasmic shuttling

S Dauvois1, R White, M G Parker

  • 1Molecular Endocrinology Laboratory, Imperial Cancer Research Fund, Lincoln's Inn Fields, London, UK.

Journal of Cell Science
|December 1, 1993
PubMed

Insights

The mouse estrogen receptor continuously moves between the nucleus and cytoplasm. Pure antiestrogens block this shuttling by preventing nuclear entry, impacting estrogen receptor function.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Endocrinology

Background:

  • The estrogen receptor (ER) plays a crucial role in cellular processes.
  • Understanding ER's subcellular localization and dynamics is key to its function.
  • ER shuttling between the nucleus and cytoplasm influences gene regulation.

Purpose of the Study:

  • To investigate the nucleocytoplasmic shuttling of the mouse estrogen receptor.
  • To determine the effect of estradiol and antiestrogens on ER localization.
  • To elucidate the mechanism by which antiestrogens affect ER shuttling.

Main Methods:

  • Heterokaryon assays to monitor protein transfer between nuclei.
  • Analysis of subcellular distribution of wild-type and mutant estrogen receptors.
  • Treatment with estradiol, 4-hydroxytamoxifen (partial antiestrogen), and ICI 182780 (pure antiestrogen).

Main Results:

  • Estrogen receptor exhibits constant nucleocytoplasmic shuttling, predominantly residing in the nucleus at steady-state.
  • The partial antiestrogen 4-hydroxytamoxifen retained the receptor in the nucleus.
  • The pure antiestrogen ICI 182780 caused cytoplasmic accumulation by inhibiting nuclear uptake, thus blocking shuttling.
  • Ligand binding is not essential for ER shuttling but can be disrupted by pure antiestrogens.

Conclusions:

  • Estrogen receptor shuttling is an intrinsic property independent of ligand binding.
  • Pure antiestrogens like ICI 182780 disrupt ER function by inhibiting nucleocytoplasmic transport.
  • Understanding ER dynamics provides insights into endocrine signaling and therapeutic strategies.

Related Concept Videos

Internal Receptors01:56

Internal Receptors

Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...